EUVIMEDEUVIMED entdecken
Open Access

AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease

Jonathan B Rosenberg, Michael G Kaplitt, Bishnu P De, Alvin Chen, Thomas Flagiello, Christiana Salami, Eduard Pey, Lingzhi Zhao, Rodolfo J Ricart Arbona, Sebastien Monette, Jonathan P Dyke, Douglas J Ballon und 5 weitere

Human Gene Therapy Clinical Development · 2018-03 · 29 (1) · 24-47

DOI: 10.1089/humc.2017.231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Gene Therapy Clinical Development, 2018-03. Verfasst von Jonathan B Rosenberg und 16 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Genetic Medicine, Weill Cornell Medical College , New York, New York. Die Arbeit wurde bisher 168-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAnimalsApolipoprotein E2Apolipoprotein E4Central Nervous SystemChlorocebus aethiopsDependovirusGenetic TherapyGenetic VectorsHEK293 CellsHumansMale

Stichwörter der Autor:innen

AAVAPOE2Alzheimer's diseaseCNSgene therapy

Substanzen

Apolipoprotein E2Apolipoprotein E4

Autor:innen und Institutionen

  • 1 Department of Genetic Medicine, Weill Cornell Medical College , New York, New York.
  • 2 Department of Neurosurgery, Weill Cornell Medical College , New York, New York.
  • 3 Appel Alzheimer's Disease Research Institute, Feil Family Brain and Mind Research Institute, Weill Cornell Medical College , New York, New York.
  • Center of Comparative Medicine and Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, The Rockefeller University , Weill Cornell Medical College, New York, New York.
  • 6 Department of Radiology, Weill Cornell Medical College , New York, New York.

Förderung

  • NCI NIH HHS

Zitieren

APA

Rosenberg, J. B., Kaplitt, M. G., De, B. P., Chen, A., Flagiello, T., Salami, C., Pey, E., Zhao, L., Ricart Arbona, R. J., Monette, S., Dyke, J. P., Ballon, D. J., Kaminsky, S. M., Sondhi, D., Petsko, G. A., Paul, S. M., & Crystal, R. G. (2018). AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease. Human Gene Therapy Clinical Development, 29(1), 24-47. https://doi.org/10.1089/humc.2017.231

Vancouver

Rosenberg JB, Kaplitt MG, De BP, Chen A, Flagiello T, Salami C, et al. AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease. Human Gene Therapy Clinical Development. 2018;29(1):24-47. doi:10.1089/humc.2017.231

BibTeX
@article{Rosenberg2018,
  author = {Rosenberg, Jonathan B and Kaplitt, Michael G and De, Bishnu P and Chen, Alvin and Flagiello, Thomas and Salami, Christiana and Pey, Eduard and Zhao, Lingzhi and Ricart Arbona, Rodolfo J and Monette, Sebastien and Dyke, Jonathan P and Ballon, Douglas J and Kaminsky, Stephen M and Sondhi, Dolan and Petsko, Gregory A and Paul, Steven M and Crystal, Ronald G},
  title = {AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease},
  journal = {Human Gene Therapy Clinical Development},
  year = {2018},
  volume = {29},
  number = {1},
  pages = {24--47},
  doi = {10.1089/humc.2017.231}
}
Kostenlos starten →